This study is currently not recruiting participants.
A Phase IIa Randomized Double-blind Placebo-controlled Multicenter Study to Assess the Safety Tlerability and Preliminary Efficacy of MEDI8968 in Subjects with Moderate to Severe Hidradentis Suppurativa
Not Recruiting
18 years - 65 years
All
Phase
N/A
1 Location
Brief description of study.
The purpose of this study is to assess the safety, tolerability, effectiveness and activity of MEDI8968 in people with hidradenitis suppurativa.
Detailed description of study
The purpose of this study is to assess the safety, tolerability, effectiveness and activity of MEDI8968 in people with hidradenitis suppurativa.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:Hidradenitis Suppurativa
Age:
18 years - 65 years
Gender: All
Updated on
19 Aug 2013.
Study ID: D5440C00001
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
